CSI Market
Sign In | Register

Biote (BTMD) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access BTMD quarterly Cash Flow →
A period-by-period view of cash flow from Biote to Dec 31 2021 helps clarify how Dec 31 2025's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income31.60
Depreciation & amortization3.67
Amortization of Other Assets0.83
Increase (Decrease) in Deferred Revenue-0.40
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed1.72
Inventories Decrease /-Increase-4.22
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation8.92
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Ajustment For Warrant Issuance Costs On Issuance Of Public Warrants-
Adjustment Unrealized Gain From Investments Held In Trust Account-
Excess Of Private Placement Warrants Fair Value Over Purchase Price-
Non Cash Lease Expense0.55
Non Cash Sponsor Share Transfers-
Fair Value Adjustment Of Earnout Liability-13.02
Increase Decrease In Operating Lease Liability-0.52
Income taxes3.98
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.96
Increase (Decrease) in Accounts Payable1.01
Increase (Decrease) in Accrued Liabilities-2.74
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital1.69
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities3.09
Discontinued operations0.00
Net Cash flow from Operating Activities35.19
Investing Activities
Capital Expenditures-6.86
Sale of Capital Items0.00
Payments to Acquire Short-term Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-6.86
Financing Activities
Short-term debt Net5.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-3.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-37.58
Proceeds From Promissory Note Related Party-
Proceeds From Business Combination-
Principal Repayments On Term Loan-6.25
Borrowings On Term Loan-
Payments Of Settlement Of Phantom Equity Right-
Proceeds From Issuance Of Shares Under Sepa-
Payments To S E P A Transaction Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-1.73
Net Cash Flow from Financing Activities-43.56
Effect of exchange rate on cash flow0.01
Discontinued operations0.00
Free Cash Flow28.33
Total Cash Flow-15.22
4 historic quarters locked

Sign in to unlock the full Biote cash flow history.

Sign In Create Free Account

About Biote Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-106099

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License